世界の最小侵襲手術(MIS)用デバイス開発動向:医療機器パイプライン分析2015

◆英語タイトル:Minimally Invasive Surgical (MIS) Devices - Medical Devices Pipeline Assessment, 2015
◆商品コード:GDME0107EPD
◆発行会社(調査会社):GlobalData
◆発行日:2015年11月12日
◆ページ数:111
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆調査対象地域:グローバル
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single UserUSD2,500 ⇒換算¥285,000見積依頼/購入/質問フォーム
Site License(同一国内共有可)USD5,000 ⇒換算¥570,000見積依頼/購入/質問フォーム
Enterprisewide License(複数国内共有可)USD7,500 ⇒換算¥855,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(支払期限と方法は調整可能、振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※レポート購入後、該当レポートに記載の英語表現や単語の意味に関しましては無料でお答えいたします。(但し、対応範囲は弊社で判断)
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。GlobalData社の概要及び新刊レポートはこちらでご確認いただけます。



当調査レポートでは、最小侵襲手術(MIS)用デバイスのグローバル製品パイプライン動向について調査・分析し、以下の構成でお届けいたします。

・最小侵襲手術(MIS)用デバイスの概要
・最小侵襲手術(MIS)用デバイスの開発動向:開発段階別分析
・最小侵襲手術(MIS)用デバイスの開発動向:セグメント別分析
・最小侵襲手術(MIS)用デバイスの開発動向:領域別分析
・最小侵襲手術(MIS)用デバイスの開発動向:規制Path別分析
・最小侵襲手術(MIS)用デバイスの開発動向:承認日(推定)別分析
・企業別最小侵襲手術(MIS)用デバイスの開発動向(パイプライン製品、進行中の治験)
・最小侵襲手術(MIS)用デバイスの最近動向
【レポートの概要】

Minimally Invasive Surgical (MIS) Devices – Medical Devices Pipeline Assessment, 2015

Summary

GlobalData’s Medical Devices sector report, “Minimally Invasive Surgical (MIS) Devices – Medical Devices Pipeline Assessment, 2015″ provides an overview of Minimally Invasive Surgical (MIS) Devices currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Minimally Invasive Surgical (MIS) Devices pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData’s team of industry experts.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

- Extensive coverage of the Minimally Invasive Surgical (MIS) Devices under development
- The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
- The report reviews the major players involved in the development of Minimally Invasive Surgical (MIS) Devices and list all their pipeline projects
- The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
- The report provides key clinical trial data of ongoing trials specific to pipeline products
- Recent developments in the segment / industry

Reasons to buy

The report enables you to –
- Formulate significant competitor information, analysis, and insights to improve R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Identify and understand important and diverse types of Minimally Invasive Surgical (MIS) Devices under development
- Develop market-entry and market expansion strategies
- Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
- In-depth analysis of the product’s current stage of development, territory and estimated launch date

【レポートの目次】

1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 4
1.2 List of Figures 6
2 Introduction 7
2.1 Minimally Invasive Surgical (MIS) Devices Overview 7
3 Products under Development 8
3.1 Minimally Invasive Surgical (MIS) devices – Pipeline Products by Stage of Development 8
3.2 Minimally Invasive Surgical (MIS) devices – Pipeline Products by Territory 9
3.3 Minimally Invasive Surgical (MIS) devices – Pipeline Products by Regulatory Path 10
3.4 Minimally Invasive Surgical (MIS) devices – Pipeline Products by Estimated Approval Date 11
3.5 Minimally Invasive Surgical (MIS) devices – Ongoing Clinical Trials 12
4 Minimally Invasive Surgical (MIS) devices – Pipeline Products under Development by Companies 13
4.1 Minimally Invasive Surgical (MIS) devices Companies – Pipeline Products by Stage of Development 13
4.2 Minimally Invasive Surgical (MIS) devices – Pipeline Products by Stage of Development 14
5 Minimally Invasive Surgical (MIS) devices Companies and Product Overview 15
5.1 Actuated Medical, Inc. Company Overview 15
5.1.1 Actuated Medical, Inc. Pipeline Products & Ongoing Clinical Trials Overview 15
5.2 Centerline Biomedical Inc. Company Overview 17
5.2.1 Centerline Biomedical Inc. Pipeline Products & Ongoing Clinical Trials Overview 17
5.3 Delft University of Technology Company Overview 19
5.3.1 Delft University of Technology Pipeline Products & Ongoing Clinical Trials Overview 19
5.4 DistalMotion Company Overview 23
5.4.1 DistalMotion Pipeline Products & Ongoing Clinical Trials Overview 23
5.5 Ethicon Endo-Surgery, Inc. Company Overview 25
5.5.1 Ethicon Endo-Surgery, Inc. Pipeline Products & Ongoing Clinical Trials Overview 25
5.6 FlexDex Company Overview 28
5.6.1 FlexDex Pipeline Products & Ongoing Clinical Trials Overview 28
5.7 Flinders University Company Overview 29
5.7.1 Flinders University Pipeline Products & Ongoing Clinical Trials Overview 29
5.8 Hadassah Medical Organization Company Overview 30
5.8.1 Hadassah Medical Organization Pipeline Products & Ongoing Clinical Trials Overview 30
5.9 Human Extensions LTD Company Overview 31
5.9.1 Human Extensions LTD Pipeline Products & Ongoing Clinical Trials Overview 31
5.10 Imperial College London Company Overview 32
5.10.1 Imperial College London Pipeline Products & Ongoing Clinical Trials Overview 32
5.11 Intuitive Surgical, Inc. Company Overview 33
5.11.1 Intuitive Surgical, Inc. Pipeline Products & Ongoing Clinical Trials Overview 33
5.12 Technische Universiteit Eindhoven Company Overview 35
5.12.1 Technische Universiteit Eindhoven Pipeline Products & Ongoing Clinical Trials Overview 35
5.13 The Johns Hopkins University Company Overview 36
5.13.1 The Johns Hopkins University Pipeline Products & Ongoing Clinical Trials Overview 36
5.14 University of California, San Francisco Company Overview 38
5.14.1 University of California, San Francisco Pipeline Products & Ongoing Clinical Trials Overview 38
5.15 University of Wisconsin-Stout Company Overview 42
5.15.1 University of Wisconsin-Stout Pipeline Products & Ongoing Clinical Trials Overview 42
5.16 Varada Innovations Inc. Company Overview 43
5.16.1 Varada Innovations Inc. Pipeline Products & Ongoing Clinical Trials Overview 43
5.17 VenX Medical LLC Company Overview 44
5.17.1 VenX Medical LLC Pipeline Products & Ongoing Clinical Trials Overview 44
5.18 XACT Robotics Ltd. Company Overview 47
5.18.1 XACT Robotics Ltd. Pipeline Products & Ongoing Clinical Trials Overview 47
6 Minimally Invasive Surgical (MIS) devices- Recent Developments 48
7 Appendix 108
7.1 Methodology 108
7.2 About GlobalData 110
7.3 Contact Us 111
7.4 Disclaimer 111

1.1 List of Tables
Table 1: Minimally Invasive Surgical (MIS) devices - Pipeline Products by Stage of Development 8
Table 2: Minimally Invasive Surgical (MIS) devices - Pipeline Products by Territory 9
Table 3: Minimally Invasive Surgical (MIS) devices - Pipeline Products by Regulatory Path 10
Table 4: Minimally Invasive Surgical (MIS) devices - Pipeline Products by Estimated Approval Date 11
Table 5: Minimally Invasive Surgical (MIS) devices - Ongoing Clinical Trials 12
Table 6: Minimally Invasive Surgical (MIS) devices Companies - Pipeline Products by Stage of Development 13
Table 7: Minimally Invasive Surgical (MIS) devices - Pipeline Products by Stage of Development 14
Table 8: Actuated Medical, Inc. Pipeline Products & Ongoing Clinical Trials Overview 15
Table 9: Grip-Act-Reposition (GAR) Miniaturized Stable Working Platform - Product Status 16
Table 10: Grip-Act-Reposition (GAR) Miniaturized Stable Working Platform - Product Description 16
Table 11: Centerline Biomedical Inc. Pipeline Products & Ongoing Clinical Trials Overview 17
Table 12: Intra-Operative Positioning System (iOPS) - Product Status 17
Table 13: Intra-Operative Positioning System (iOPS) - Product Description 18
Table 14: Delft University of Technology Pipeline Products & Ongoing Clinical Trials Overview 19
Table 15: Endovascular Instrument - Product Status 19
Table 16: Endovascular Instrument - Product Description 19
Table 17: Fiber-Top Controlled Adaptable Stiffness Needle - Product Status 20
Table 18: Fiber-Top Controlled Adaptable Stiffness Needle - Product Description 20
Table 19: Low-friction Surgical Grasper - Product Status 21
Table 20: Low-friction Surgical Grasper - Product Description 21
Table 21: System With Shared Control Of Robotic Needle - Product Status 22
Table 22: System With Shared Control Of Robotic Needle - Product Description 22
Table 23: DistalMotion Pipeline Products & Ongoing Clinical Trials Overview 23
Table 24: Disposable Surgical Device - Product Status 23
Table 25: Disposable Surgical Device - Product Description 23
Table 26: Reusable Surgical Device - Product Status 24
Table 27: Reusable Surgical Device - Product Description 24
Table 28: Ethicon Endo-Surgery, Inc. Pipeline Products & Ongoing Clinical Trials Overview 25
Table 29: Magnetic Anchoring And Guidance System - Product Status 26
Table 30: Magnetic Anchoring And Guidance System - Product Description 26
Table 31: Next Generation MIS Device - Product Status 27
Table 32: Next Generation MIS Device - Product Description 27
Table 33: FlexDex Pipeline Products & Ongoing Clinical Trials Overview 28
Table 34: FlexDex Device - Product Status 28
Table 35: FlexDex Device - Product Description 28
Table 36: Flinders University Pipeline Products & Ongoing Clinical Trials Overview 29
Table 37: Bone Graft Delivery Instrument - Product Status 29
Table 38: Bone Graft Delivery Instrument - Product Description 29
Table 39: Hadassah Medical Organization Pipeline Products & Ongoing Clinical Trials Overview 30
Table 40: Transdermal Antenna - Product Status 30
Table 41: Transdermal Antenna - Product Description 30
Table 42: Human Extensions LTD Pipeline Products & Ongoing Clinical Trials Overview 31
Table 43: Hand Avatar - Product Status 31
Table 44: Hand Avatar - Product Description 31
Table 45: Imperial College London Pipeline Products & Ongoing Clinical Trials Overview 32
Table 46: iSnake Surgical System - Product Status 32
Table 47: iSnake Surgical System - Product Description 32
Table 48: Intuitive Surgical, Inc. Pipeline Products & Ongoing Clinical Trials Overview 33
Table 49: da Vinci Sp Surgical System - Product Status 34
Table 50: da Vinci Sp Surgical System - Product Description 34
Table 51: Technische Universiteit Eindhoven Pipeline Products & Ongoing Clinical Trials Overview 35
Table 52: PITON Teleoperated Steerable Needle - Product Status 35
Table 53: PITON Teleoperated Steerable Needle - Product Description 35
Table 54: The Johns Hopkins University Pipeline Products & Ongoing Clinical Trials Overview 36
Table 55: Dexterous Tool For Minimally Invasive Surgery - Product Status 37
Table 56: Dexterous Tool For Minimally Invasive Surgery - Product Description 37
Table 57: University of California, San Francisco Pipeline Products & Ongoing Clinical Trials Overview 38
Table 58: Magnamosis - Compression Anastomosis - Product Status 39
Table 59: Magnamosis - Compression Anastomosis - Product Description 39
Table 60: University of California, San Francisco - Ongoing Clinical Trials Overview 40
Table 61: Magnamosis - Compression Anastomosis - Magnetic Compression Anastomosis (Magnamosis) First-in-human Study of Feasibility and Safety 41
Table 62: University of Wisconsin-Stout Pipeline Products & Ongoing Clinical Trials Overview 42
Table 63: Interleaved Continuum-rigid Manipulator - Product Status 42
Table 64: Interleaved Continuum-rigid Manipulator - Product Description 42
Table 65: Varada Innovations Inc. Pipeline Products & Ongoing Clinical Trials Overview 43
Table 66: ArthroTense - Product Status 43
Table 67: ArthroTense - Product Description 43
Table 68: VenX Medical LLC Pipeline Products & Ongoing Clinical Trials Overview 44
Table 69: VenX Reach - Product Status 44
Table 70: VenX Reach - Product Description 44
Table 71: VenX Medical LLC - Ongoing Clinical Trials Overview 45
Table 72: VenX Reach - First-In-Man Study For The Treatment of Varicose Veins 46
Table 73: XACT Robotics Ltd. Pipeline Products & Ongoing Clinical Trials Overview 47
Table 74: XACT System - Product Status 47
Table 75: XACT System - Product Description 47
Table 76: Glossary 109

1.2 List of Figures
Figure 1: Minimally Invasive Surgical (MIS) devices - Pipeline Products by Stage of Development 8
Figure 2: Minimally Invasive Surgical (MIS) devices - Pipeline Products by Territory 9
Figure 3: Minimally Invasive Surgical (MIS) devices - Pipeline Products by Regulatory Path 10
Figure 4: Minimally Invasive Surgical (MIS) devices - Pipeline Products by Estimated Approval Date 11
Figure 5: Minimally Invasive Surgical (MIS) devices - Ongoing Clinical Trials 12

【掲載企業】

Actuated Medical, Inc.
Centerline Biomedical Inc.
Delft University of Technology
DistalMotion
Ethicon Endo-Surgery, Inc.
FlexDex
Flinders University
Hadassah Medical Organization
Human Extensions LTD
Imperial College London
Intuitive Surgical, Inc.
Technische Universiteit Eindhoven
The Johns Hopkins University
University of California, San Francisco
University of Wisconsin-Stout
Varada Innovations Inc.
VenX Medical LLC
XACT Robotics Ltd.

【免責事項】
※当レポート上の情報/データは調査会社が信頼できると判断した情報源から入手したものに基づき作成しましたが、その正確性・完全性を保証するものではありません。当レポートに記載された情報/データ/見解/仮説などは作成時点又は発行時点における調査会社の判断であり、その後の状況変化に応じて変更される場合があります。当レポート上の情報/データに基づいたお客様の意思決定又は実行による結果について、調査会社/発行会社/販売会社H&Iグローバルリサーチ(株)はその責を負いかねますのでご了承ください。英文資料の紹介ページにおける日本語題名/概要/目次はH&Iグローバルリサーチ(株)が翻訳した内容であり、翻訳の正確性・完全性を保証するものではありません。

★調査レポート[世界の最小侵襲手術(MIS)用デバイス開発動向:医療機器パイプライン分析2015]についてメールでお問い合わせはこちら


※世界の市場調査資料 総合販売サイトMarketReport.jpはH&Iグローバルリサーチ株式会社が運営しております。海外進出、グローバル事業戦略策定、新規事業機会の発掘、競合他社の動向把握などに必要な情報やインサイトをお客様にご提供しております。H&Iグローバルリサーチ(登録第5864124号)及びH&I(登録第5783645号)はH&Iグローバルリサーチ株式会社の商標です。
※当サイトでは2016年12月05日現在 219,162 件の調査レポートを取り扱っております。当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。

◆H&Iグローバルリサーチのお客様(例)◆